GILD

Gilead Sciences, Inc. News Headlines

$93.79
*  
0.80
0.86%
Get GILD Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Merck, J&J, Baxter Provide Healthy Dividend Stream
7/30/2014 7:01:00 PM - Investor's Business Daily

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog
7/30/2014 12:04:00 PM - Zacks.com

Gilead's Massive Undervaluation: A Pictorial Overview
7/30/2014 9:10:00 AM - Seeking Alpha

Cramer's Mad Money - The Pause That Depresses (7/29/14)
7/30/2014 5:20:00 AM - Seeking Alpha

What I Bought Over The Last 4 Months, And Why I Bought It
7/30/2014 3:25:00 AM - Seeking Alpha

Biotech ETF Price Swings May Signal Need For Caution
7/28/2014 6:03:00 PM - Investor's Business Daily

Gilead's Oncology Drug Recommended for Approval in the EU - Analyst Blog
7/28/2014 5:40:00 PM - Zacks.com

Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
7/28/2014 5:15:00 PM - Zacks.com

Raising My $100 Price Target For Gilead Sciences On Sovaldi Sales
7/28/2014 4:08:00 PM - Seeking Alpha

Expect Gilead Sciences To Outperform
7/28/2014 2:26:00 PM - Seeking Alpha

Gilead: Does It Pass The Trial As A Long-Term Investment?
7/28/2014 1:59:00 PM - Seeking Alpha

Conatus Pharmaceuticals: Large Upside With Attractive Risk And Income Profiles
7/28/2014 9:50:00 AM - Seeking Alpha

#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise
7/28/2014 6:59:45 AM - Benzinga

Bold Bulls Dare Meek Bears To Take Another Crack
7/28/2014 5:11:00 AM - Seeking Alpha

Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira
7/26/2014 3:05:00 AM - Seeking Alpha

Noteworthy ETF Inflows: XLV, MRK, GILD, CELG
7/25/2014 11:13:51 AM - BNK Invest

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
7/25/2014 10:52:00 AM - Seeking Alpha

Gilead Sciences Gets Positive CHMP Opinion For Zydelig - Quick Facts
7/25/2014 7:30:00 AM - RTT News

Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
7/24/2014 3:45:00 PM - Zacks.com

A Re-Analysis Of Gilead After Q2 Results And The Early Idelalisib Approval
7/24/2014 1:50:00 PM - Seeking Alpha

Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
7/24/2014 1:48:13 PM - Zacks.com

Gilead: Even This Raging Bull Was Too Pessimistic
7/24/2014 12:30:00 PM - Seeking Alpha

Why Gilead Is A Better Buy Than This Rival
7/24/2014 11:26:00 AM - Seeking Alpha

Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year
7/24/2014 11:25:00 AM - Seeking Alpha

Gilead Sciences - Sovaldi Momentum Continues, Appeal Remains
7/24/2014 10:28:00 AM - Seeking Alpha